CIDARA THERAPEUTICS, INC. Research and Development in Process
CIDARA THERAPEUTICS, INC. reported Research and Development in Process of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentInProcess · last filed 2017-03-15
- CIDARA THERAPEUTICS, INC. research and development in process for the quarter ending 2014-12-31 was $0.00.
- CIDARA THERAPEUTICS, INC. research and development in process for the quarter ending 2014-09-30 was $0.00.
- CIDARA THERAPEUTICS, INC. research and development in process for the quarter ending 2014-06-30 was $1.61M.
- CIDARA THERAPEUTICS, INC. research and development in process for fiscal 2016 was $0.00.
- CIDARA THERAPEUTICS, INC. research and development in process for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- CIDARA THERAPEUTICS, INC. research and development in process for fiscal 2014 was $1.61M.
| Period end | Research and Development in Process 3 month | Research and Development in Process 6 month | Research and Development in Process 9 month | Research and Development in Process 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-15 | |||
| 2015-12-31 | $0.00 10-K · filed 2017-03-15 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $0.00 derived: sum of 2 quarters · filed 2017-03-15 | $1.61M derived: sum of 3 quarters · filed 2017-03-15 | $1.61M 10-K · filed 2017-03-15 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $1.61M derived: sum of 2 quarters · filed 2015-11-16 | $1.61M 10-Q · filed 2015-11-16 | |
| 2014-06-30 | $1.61M 10-Q · filed 2015-08-11 | $1.61M 10-Q · filed 2015-08-11 |